Trevi Therapeutics Inc (NASDAQ:TRVI)
| 2.21 BATS BZX Real-Time Price As of 12:05pm ET |  +0.05 / +2.31%Today’s Change | 1.43 Today|||52-Week Range 3.50 | +14.51% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 4.0K | 4.0K | 23.0K | -- | ||
| Operating Expenses | Gross Income | -4.0K | -4.0K | -23.0K | -- | |
| General Expenses | 8.6M | 8.2M | 18.4M | -- | ||
| Research And Development | 6.9M | 6.1M | 14.1M | -- | ||
| Total Operating Expenses | 8.6M | 8.2M | 18.4M | -- | ||
| Non-Operating Expenses | Operating Income | -8.6M | -8.2M | -18.4M | -- | |
| Extraordinary Credit | 212.0K | 0.00 | 0.00 | -- | ||
| Extraordinary Charge | -76.0K | -1.4M | -2.2M | -- | ||
| Interest Expense On Debt | 2.6M | 3.3M | 174.0K | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -11.1M | -12.9M | -20.7M | -- | |
| Income Taxes | -8.0K | -26.0K | -124.0K | -- | ||
| Preferred Dividend | -4.4M | -320.0K | -5.0M | -- | ||
| Net Income | -11.1M | -12.9M | -20.5M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 16.1M | 16.1M | 17.8M | -- | |
| Shares To Calculate EPS Diluted | 16.1M | 16.1M | 17.8M | -- | ||
| Earnings Per Share | EPS | -$0.42 | -$0.78 | -$1.44 | -- | |
| EPS Diluted | -$0.42 | -$0.78 | -$1.44 | -- | ||
